• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌:在弥散加权成像的弥散系数图上观察肿瘤的可见性比较。

Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.

机构信息

Department of Radiology, New York University Langone Medical Center, 560 First Ave., TCH-HW202, New York, NY 10016, USA.

出版信息

AJR Am J Roentgenol. 2011 Jan;196(1):123-9. doi: 10.2214/AJR.10.4738.

DOI:10.2214/AJR.10.4738
PMID:21178056
Abstract

OBJECTIVE

The purpose of our study was to compare the visibility of prostate cancer on trace diffusion-weighted (DW) images and the apparent diffusion coefficient (ADC) map.

MATERIALS AND METHODS

In this retrospective study, 45 patients with prostate cancer underwent preoperative MRI, including DW imaging (DWI) (b values 0, 500, and 1,000 s/mm(2)). A single observer reviewed the images in conjunction with tumor maps constructed from prostatectomy. For 132 peripheral zone (PZ) tumor foci, the visibility and contrast relative to benign PZ were recorded for T2-weighted imaging, trace DWI b500 images, trace DWI b1,000 images, and ADC maps. Trace DWI b1,000 images and ADC maps were compared in terms of Gleason score, size, normalized T2 signal intensity, ADC, and normalized ADC of visible tumors.

RESULTS

For each image set, the percentage of visible tumor foci and contrast relative to benign PZ were as follows: T2-weighted imaging, 80.3% and 0.411; trace DWI b500, 26.5% and 0.131; trace DWI b1,000, 46.2% and 0.119; and ADC maps, 62.1% and 0.309. Forty-seven tumor foci were visible on both trace DWI b1,000 images and ADC maps, 14 only on trace DWI b1,000 images, 35 only on ADC maps, and 36 on neither image set. There was no significant difference in Gleason score, size, normalized T2 signal intensity, ADC, or normalized ADC between tumors visible only on trace DWI b1,000 images and those visible only on ADC maps.

CONCLUSION

Given a greater proportion of tumors visible on the ADC map than trace DWI and greater contrast relative to benign PZ on the ADC map, we suggest that, when performing DWI of the prostate, careful attention be given to the ADC map for tumor identification.

摘要

目的

本研究旨在比较前列腺癌在 trace 扩散加权(DW)图像和表观扩散系数(ADC)图上的可视性。

材料和方法

在这项回顾性研究中,45 例前列腺癌患者接受了术前 MRI 检查,包括 DW 成像(DWI)(b 值为 0、500 和 1000 s/mm²)。一位观察者结合前列腺切除术构建的肿瘤图回顾性分析图像。对于 132 个外周带(PZ)肿瘤灶,记录 T2 加权成像、trace DWI b500 图像、trace DWI b1000 图像和 ADC 图上肿瘤的可视性和对比。比较 trace DWI b1000 图像和 ADC 图在 Gleason 评分、大小、归一化 T2 信号强度、ADC 和可见肿瘤的归一化 ADC 方面的差异。

结果

对于每个图像集,可见肿瘤灶的百分比和与良性 PZ 的对比如下:T2 加权成像,80.3%和 0.411;trace DWI b500,26.5%和 0.131;trace DWI b1000,46.2%和 0.119;ADC 图,62.1%和 0.309。47 个肿瘤灶在 trace DWI b1000 图像和 ADC 图上均可见,14 个仅在 trace DWI b1000 图像上可见,35 个仅在 ADC 图上可见,36 个在两个图像集上均不可见。仅在 trace DWI b1000 图像上可见的肿瘤和仅在 ADC 图上可见的肿瘤在 Gleason 评分、大小、归一化 T2 信号强度、ADC 或归一化 ADC 方面无显著差异。

结论

由于 ADC 图上可见肿瘤的比例大于 trace DWI,并且相对于良性 PZ 的对比度更大,因此我们建议在进行前列腺 DWI 时,应仔细关注 ADC 图以识别肿瘤。

相似文献

1
Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.前列腺癌:在弥散加权成像的弥散系数图上观察肿瘤的可见性比较。
AJR Am J Roentgenol. 2011 Jan;196(1):123-9. doi: 10.2214/AJR.10.4738.
2
Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.外周带前列腺癌的弥散加权 MRI:肿瘤表观弥散系数与 Gleason 评分及核心穿刺活检肿瘤百分比的比较。
AJR Am J Roentgenol. 2010 Apr;194(4):W316-22. doi: 10.2214/AJR.09.2651.
3
Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.前列腺癌与活检后出血:T2 加权成像和弥散加权成像诊断。
J Magn Reson Imaging. 2010 Jun;31(6):1387-94. doi: 10.1002/jmri.22172.
4
Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.前列腺弥散加权成像:比较 b1000 和 b2000 图像集对指数病变的检测。
J Magn Reson Imaging. 2013 Sep;38(3):694-700. doi: 10.1002/jmri.24016. Epub 2013 Jan 31.
5
Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.多参数磁共振成像检测前列腺癌:定量T2、扩散加权成像和动态对比增强磁共振成像的逻辑回归分析
J Magn Reson Imaging. 2009 Aug;30(2):327-34. doi: 10.1002/jmri.21824.
6
High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.3T 下高 b 值扩散加权成像检测前列腺癌:b 值分别为 1000 和 2000 s/mm2 的比较。
AJR Am J Roentgenol. 2010 Jan;194(1):W33-7. doi: 10.2214/AJR.09.3004.
7
Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.使用相控阵线圈在3T场强下通过扩散加权成像预测前列腺癌位置的价值:初步结果
Invest Radiol. 2007 Dec;42(12):842-7. doi: 10.1097/RLI.0b013e3181461d21.
8
Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.联合T2加权和弥散加权磁共振成像用于前列腺癌定位
AJR Am J Roentgenol. 2007 Aug;189(2):323-8. doi: 10.2214/AJR.07.2211.
9
Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.前列腺癌:利用T2加权图像的表观扩散系数图进行检测——一项多阅片者研究
Radiology. 2009 Jan;250(1):145-51. doi: 10.1148/radiol.2501080207. Epub 2008 Nov 18.
10
High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T.3T场强下高b值扩散加权磁共振成像用于前列腺癌检测
Clin Radiol. 2014 Nov;69(11):1165-70. doi: 10.1016/j.crad.2014.07.013. Epub 2014 Aug 30.

引用本文的文献

1
Exponential apparent diffusion coefficient in evaluating prostate cancer at 3 T: preliminary experience.3T场强下指数表观扩散系数在前列腺癌评估中的初步经验
Br J Radiol. 2016;89(1058):20150470. doi: 10.1259/bjr.20150470. Epub 2015 Dec 10.
2
Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate.经直肠超声引导下前列腺穿刺活检后多参数磁共振成像定量参数的演变
Prostate Cancer Prostatic Dis. 2015 Dec;18(4):343-51. doi: 10.1038/pcan.2015.33. Epub 2015 Jul 21.
3
DWI of Prostate Cancer: Optimal b-Value in Clinical Practice.
前列腺癌的扩散加权成像:临床实践中的最佳b值
Prostate Cancer. 2014;2014:868269. doi: 10.1155/2014/868269. Epub 2014 Feb 18.
4
Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection.3T 磁共振成像下前列腺的扩散加权成像:对图像质量和肿瘤检测的影响
Eur Radiol. 2013 Nov;23(11):3170-7. doi: 10.1007/s00330-013-2917-8. Epub 2013 Jun 12.
5
Diffusion-weighted magnetic resonance imaging for the evaluation of prostate cancer: optimal B value at 3T.磁共振弥散加权成像在前列腺癌诊断中的应用:3.0T 下最佳 B 值。
Korean J Radiol. 2013 Jan-Feb;14(1):61-9. doi: 10.3348/kjr.2013.14.1.61. Epub 2012 Dec 28.
6
The emerging role of diffusion-weighted MRI in prostate cancer management.弥散加权 MRI 在前列腺癌管理中的新作用。
Nat Rev Urol. 2012 Jan 17;9(2):94-101. doi: 10.1038/nrurol.2011.222.
7
Diffusion-weighted MR imaging in gynecologic cancers.磁共振弥散加权成像在妇科肿瘤中的应用。
J Gynecol Oncol. 2011 Dec;22(4):275-87. doi: 10.3802/jgo.2011.22.4.275. Epub 2011 Dec 5.
8
What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T?在 3T 磁共振弥散加权成像中,描述前列腺癌的最佳 b 值是多少?
Eur Radiol. 2012 Mar;22(3):703-9. doi: 10.1007/s00330-011-2298-9. Epub 2011 Oct 5.